For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Published 2010-05-14 00:00:00
This page contains additional content about the article Melatonin prolonged-release tablets (Circadin)
for primary insomnia in older people, first published in NPS RADAR in May 2010.
|
Getting to sleep (GTS) How would you compare getting sleep using the medicine with how you usually get to sleep without the medicine?
|
|
Quality of sleep (QOS) How would you compare the quality of sleep using the medicine with your usual non-medicated sleep?
|
|
Awakening from sleep (AFS) How did your awakening after being medicated compare with your usual pattern of awakening without the medicine?
|
|
Behaviour following wakening (BFW) How did you feel when you woke up?
How do you feel now?
How was your sense of balance and co-ordination upon getting up?
|
Parrott AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychological investigations — a review. Psychopharmacol 1980; 71:173–9. [PubMed]
Date published: 2010-05-14 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.